Open
SectorHealthcare
1.03 -7.21
24h
Min
1.03
Max
1.09
Income | 15M -38M |
---|---|
Sales | -231K 1.6M |
EPS | -0.32 |
Profit margin | -2,309.454 |
Employees | 181 |
EBITDA | 4.3M -38M |
Recommendations | Neutral |
---|---|
12 Months Forecast | +342.73% upside |
Next Earnings | 11 sie 2025 |
---|
Market Cap | 14M 136M |
---|---|
Previous open | 8.24 |
Previous close | 1.03 |
By Acuity
50%
50%
154 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 4.87 USD 342.73%
High 12 USD
Low 2 USD
Based on 9 Wall Street analysts offering 12 month price targets forFate Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$